Renal cell carcinoma for the nephrologist

被引:79
|
作者
Perazella, Mark A. [1 ,2 ]
Dreicer, Robert [3 ]
Rosner, Mitchell H. [4 ]
机构
[1] Yale Univ, Sch Med, Sect Nephrol, 333 Cedar St, New Haven, CT 06520 USA
[2] Vet Affairs Med Ctr, West Haven, CT USA
[3] Univ Virginia Hlth Syst, Div Hematol Oncol, Charlottesville, VA USA
[4] Univ Virginia Hlth Syst, Div Nephrol, Charlottesville, VA USA
关键词
acute kidney injury; chronic kidney disease; immunotherapy; nephrotoxicity; renal cell carcinoma; targeted anticancer agents; von Hippel-Lindau; CHRONIC KIDNEY-DISEASE; TUMOR-SUPPRESSOR GENE; VON-HIPPEL-LINDAU; NEPHRON-SPARING SURGERY; HOGG-DUBE-SYNDROME; CANCER-SPECIFIC MORTALITY; PHASE-III TRIAL; PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; URINARY-TRACT;
D O I
10.1016/j.kint.2018.01.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal cell carcinoma (RCC), a malignancy whose incidence is increasing, is frequently encountered in general nephrology practice when acute and chronic kidney disease occurs in the course of disease. Importantly, when kidney disease develops in the setting of RCC, mortality is significantly increased with patients often dying of a non-cancer-related complication of kidney disease. As such, practicing nephrologists need to have a working knowledge of this cancer's biology, treatment, and complications. Nephrologists should be involved in all aspects of the care of patients with RCC including in the acute setting prior to nephrectomy and in the chronic setting for patients with post-nephrectomy chronic kidney disease and those receiving potentially nephrotoxic anticancer agents. This collaborative approach to RCC care will hopefully improve patient outcomes.
引用
收藏
页码:471 / 483
页数:13
相关论文
共 50 条
  • [1] The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma
    Hu, Susie L.
    Chang, Anthony
    Perazella, Mark A.
    Okusa, Mark D.
    Jaimes, Edgar A.
    Weiss, Robert H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (08): : 2227 - 2237
  • [2] The Nephrologist's Management of Renal Cell Carcinoma After Kidney Surgery
    Hu, Susie L.
    SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 59 - 68
  • [3] Renal biopsy - consequences for the nephrologist
    Grabensee, B
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (36) : 2012 - 2016
  • [4] When is metastatic renal cell carcinoma not renal cell carcinoma?
    Billings, S.
    Henley, J.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (01) : 99 - 100
  • [5] Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
    Rafael Fúnez
    Teresa Pereda
    Isabel Rodrigo
    Luis Robles
    Carlos González
    Diagnostic Pathology, 2
  • [6] Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
    Funez, Rafael
    Pereda, Teresa
    Rodrigo, Isabel
    Robles, Luis
    Gonzalez, Carlos
    DIAGNOSTIC PATHOLOGY, 2007, 2 (1)
  • [7] Renal anemia: a nephrologist's view
    Tsagalis, G.
    HIPPOKRATIA, 2011, 15 : 39 - 43
  • [8] A kidney carcinoma with features of clear cell renal carcinoma and transitional cell carcinoma: a combined renal cell and transitional cell carcinoma?
    Terada, T
    Inatsuchi, H
    Yasuda, M
    Osamura, Y
    VIRCHOWS ARCHIV, 2003, 443 (04) : 583 - 585
  • [9] A kidney carcinoma with features of clear cell renal carcinoma and transitional cell carcinoma: a combined renal cell and transitional cell carcinoma?
    Tadashi Terada
    Hiroaki Inatsuchi
    Masanori Yasuda
    Yoshiyuki Osamura
    Virchows Archiv, 2003, 443 : 583 - 585
  • [10] Fumarate hydratase deficient renal cell carcinoma - a case of hereditary leiomyomatosis and renal cell carcinoma - associated renal cell carcinoma?
    Sa, D.
    Costa, F.
    Vieira, F. S.
    Vizcaino, J. R.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S362 - S362